DeJarnette PACS transitions boomContextVision readies 3D ultrasound filter
GE Healthcare and the Qatar Foundation have agreed to form a joint venture that will expand the company's IT business in the Middle East and Africa. The venture, headquartered at the Qatar Science & Technology Park (QSTP) in Doha, will build on GE's existing partnership with QSTP. It will focus on developing next-generation healthcare technologies adapted specifically to local needs. It will also provide marketing, sales, and distribution services in partnership with GE Healthcare's existing infrastructure across the region. The joint venture will be equally owned by GE Healthcare and the Qatar Foundation, with the goal of achieving more than $200 million of annual revenues within five to seven years.
Transitions from legacy PACS to newer systems are going strong. Over the next two and a half months, DeJarnette Research is scheduled to perform 30 such transitions. The contracts represent over six million studies to be migrated with the company's PACSware Migration Gateway toolkit, according to the Towson, MD, firm. These contracts bring the total number of sites transitioned by DeJarnette to more than 250 involving more than 55 million studies.
Software developer ContextVision will introduce an image enhancement tool for 3D ultrasound April 2 at the American Institute of Ultrasound in Medicine meeting in New York City. The GOPiCE US software brings out details in volumetric images otherwise hidden by speckle and noise, according to the company, and it does so in real-time. The software easily integrates into modern software-based ultrasound systems, according to ContextVision.
FDA Clears AI-Powered Ultrasound Software for Cardiac Amyloidosis Detection
November 20th 2024The AI-enabled EchoGo® Amyloidosis software for echocardiography has reportedly demonstrated an 84.5 percent sensitivity rate for diagnosing cardiac amyloidosis in heart failure patients 65 years of age and older.
The Reading Room: Racial and Ethnic Minorities, Cancer Screenings, and COVID-19
November 3rd 2020In this podcast episode, Dr. Shalom Kalnicki, from Montefiore and Albert Einstein College of Medicine, discusses the disparities minority patients face with cancer screenings and what can be done to increase access during the pandemic.